* Mesa Laboratories Inc MLAB.OQ reported quarterly
adjusted
earnings of 11 cents per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was
for earnings of 37 cents per share.
* Revenue fell 5.6% to $55.59 million from a year ago;
analysts
expected $57.40 million.
* The mean earnings estimate of analysts had risen by
about 63% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Mesa Laboratories Inc shares had fallen by 17.6% this
quarter and lost 13.4% so far this year.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $205.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
25 at 01:32 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 0.37 0.11 Missed
Dec. 31 2022 0.14 0.08 Missed
Sep. 30 2022 -0.31 0.24 Beat
Jun. 30 2022 1.00 -0.27 Missed